Home
Company
Profile
Careers
Collaborations
Conferences
Ion Channel Retreat
Retreat 2010
   Speaking Program
     Disease Targets
     K-Channel Targets
     Pain Targets
     TRP Channels
     Screening
     Cardiac Pharmacology
     Structure & Function
     Posters
   Registration
   Sponsors
Retreat 2009
Retreat 2008
Retreat 2007
Retreat 2006
Retreat 2005
Retreat 2004
Retreat 2003
Contact Us
Site Map
Automated Liquid Handling
Chemistry Analysers
Ion Channel Research
Elemental Analysis
Water Purification
OEM
Resources
Home > Ion Channel Retreat 2010

8th Annual Ion Channel Retreat

Vancouver BC, Canada • June 28 – 30, 2010
Hyatt Regency Hotel, Vancouver

2010 Ion Channel Retreat

Speaking Program (Subject to Change)

June 28th, 2010

8:00 am – Registration and Breakfast

8:50 am – Welcome & Opening Remarks
Saranna Brugger - Program Coordinator
Aurora Biomed

Session 1: Ion Channels as Disease Targets

2010 Ion Channel Retreat 8:55 – Chairperson's Remarks
John Dunlop
Executive Director                    
Pfizer 

9:00 - 9:25 Modes of action of a7 nicotinic receptors
John Dunlop                            
Executive Director                    
Pfizer  

9:30 - 9:55 Development of investigational ion channel modulators of mutant CFTR for the treatment of cystic fibrosis
Fredrick VanGoor                     
Research Fellow II 
Vertex Pharmaceuticals

Return to Top of Page

Session 2: Ion Channels as Pain Targets


10:00 – Chairperson's Remarks
Alan Wickenden
Research Fellow
Johnson & Johnson PRD

10:05 - 10:30 Sodium Channels as Pain Targets
Birgit Priest
Senior Research Fellow
Merck Research Laboratories

10:35 - 10:50 Coffee Break - Meeting Foyer

10:55 - 11:20 The role of gap junctions in neuropathic pain
Jianguo Cheng
Staff Physician
Cleveland Clinic

11:25 - 11:50 Drug discovery using a panel of NaV1.7 cell lines comprising alpha and beta subunits resulted in potent analgesics
Kambiz Shekdar
CSO
Chromocell Corporation

11:55 - 12:55 Lunch - English Bay Room

Return to Top of Page

Session 3: K-Channels - links to Pain & Disease


13:00 – Chairperson's Remarks
John Dunlop
Executive Director
Pfizer

13:05 - 13:30 Kv1.3 channel mobility and function in Systemic Lupus Erythematosus
Laura Conforti                          
Associate Professor                 
University of Cincinnati             

13:35 - 14:00 Smooth Muscle Kv7 Potassium Channels: Important new therapeutic Targets
Kenneth Byron   
Associate Professor                 
Loyola University                      

14:05 - 14:30 Design of a highly selective small-molecule inhibitor of the renal outer medullary potassium channel (ROMK)
Jerod Denton                           
Assistant Professor                  
Vanderbilit University

14:35 - 14:50 Coffee Break - Meeting Foyer

Return to Top of Page

Session 4: TRP Channels – links to Pain & Disease

14:55 Chairperson's Remarks
Alan Wickenden
Research Fellow
Johnson & Johnson PRD

15:00 - 15:25 The Sensory Irritant Receptor TRPA1 is essential for airway inflammation and hyperreactivity in asthma
Sven-Eric Jordt
Assistant Professor                  
Yale University of Medicine

15:30 - 15:55 Pharmacology and Function of Cold-Activated Trpm8 Channels
Felix Viana de la Iglesia            
Tenured Investigator CSIC         
Universidad Migueul Hernandez 

16:00 - 16:25 TRPV6 is the focus for a targeted management of ovarian cancer: early detection and treatment.
Jack Stewart
Chief Scientific Officer
Soricimed Biopharma Inc.

Return to Top of Page

June 29th, 2010

8:00 am – Breakfast

8:30 am – Opening Remarks
Saranna Brugger - Program Coordinator
Aurora Biomed

Session 5: Ion Channel Screening Technologies


8:35 – Chairperson's Remarks
Alan Wickenden
Research Fellow
Johnson & Johnson PRD

8:40 - 9:05 Introduction to the IonWorks Barracuda System: An Automated Electrophysiology Platform for Measuring Ligand- or Voltage-gated Channels Simultaneously in 384 Wells
Xin Jiang                                 
Application Scientist                 
Molecular Devices Inc.  

9:10 - 9:35 Development of an HTS Flux Assay for TRP Channels using ICR8000
Sikander Gill                             
Application Scientist & Senior R&D                                                       
Aurora Biomed

9:40 - 10:05 Excitement over Automated Patch Clamp: heat activation of trpv1 and action potentials of cardiomyocytes
Rodolfo Haedo 
General Manager 
Nanion Technologies Inc

10:10 - 10:30 Coffee Break - Meeting Foyer
Return to Top of Page

10:30 - 10:55 Building ion channel assays for cardiac liability and target profiling use on automated patch-clamp platforms
Stephen Hess                          
Senior R&D Manager                
Millipore

11:00 - 11:25 Biophysical and pharmacological characterization of ligand gated ion channels in multi-hole mode on Qpatch HTX
Rikke Schrøder  
Application Scientist                 
Sophion Bioscicence

11:30 - 12:30 Lunch - English Bay Room

12:35 - 13:00 hERG in silico 3D Modelling to Guide Compound Development in a Histamine H3 Receptor Antagonist program
Andreas Ebneth                       
Group Leader In Vitro Neurobiology                                                      
Evotec 

13:05 - 13:30 Evolving strategic options for ion channel discovery research
Andrew Southan                       
Director, Ion Channel Biology    
Biofocus

13:35 - 14:00 Cardiomyocytes for Advanced Electrophysiological Drug Screening: Comparison of Mouse ES and Human iPS Cell-derived Cells
Ralf Kettenhofen                      
Senior Scientist
Axiogenesis AG           

14:05 - 14:25 Coffee Break - Meeting Foyer
Return to Top of Page

14:25 - 14:50 Development of a high throughput IonFlux assay to detect positive allosteric modulators of the GABAA receptor
Speaker for Fluxion Biosciences
Juha Kammonen
Pfizer Global Research & Development

14:55 - 15:20 Application of a novel patch-clamp chip interface to cultured neurons
Marzia Martina
Research Officer
National Research Council of Canada

17:00 – Meet in Hyatt lobby for boat cruise
17:30 - 21:30 – Boat cruise sponsored by Millipore.

Return to Top of Page

June 30th, 2010

8:00 am – Coffee & Tea

8:30 am – Opening Remarks
Saranna Brugger - Program Coordinator
Aurora Biomed

Session 6: Cardiac Ion Channel Pharmacology


8:35 - Chairperson's Remarks
Gul Erdemli
Head of Ion Channel Group
Novartis

8:40 - 9:05 Cardiac Ion Channel Pharmacology
Gul Erdemli
Head of Ion Channel Group
Novartis

9:10 - 9:35 How do hERG channels activate?  Insight from gating currents and tetramethylrhodamine fluorescence
David Fedida
Professor & Associate Head  
University of British Columbia

9:40 - 10:05 The voltage sensor of Iks channels may be an ideal drug target in the prevention of cardiac arrhythmias
Dick Wu
Professor 
Washington University in St. Louis

10:10 - 10:30 Breakfast - English Bay View Room

10:30 - 10:55 Cardiomyocytes derived human IPS cells
Blake D. Anson
Director hERG Screening Services
Cellular Dynamics International 
Return to Top of Page

 

Session 7: Structure & Function of Ion Channels


11:00 Chairperson's Remarks
Gul Erdemli
Head of Ion Channel Group
Novartis

11:05 - 11:30 Novel Approaches in Targeting Ion Channels
James Prudent
Centrose
President & CEO

11:35 - 12:35 Lunch - Served in Foyer / Meeting Room

12:40 - 13:05 8-pCPT-cGMP is a potent epithelial Na channel opener
Hong-Long (James) Ji
Associate Professor
University of Texas Health Science Center

13:10 - 13:35 Ion Channels Properties of Motor neurons Differentiation from iPSCs
Zhiyuan Li 
Principal Investigator
Guangzhou Institute of Biomedicine and Health

13:40 - 14:00 Closing Remarks
Dong Liang
President & CEO
Aurora Biomed

Return to Top of Page

Poster Presentation Schedule


June 28th, 2010

Identification of C-terminal basic residues involved in the chemical and voltage-dependent activation of TRPA1
Lucie Sura
PhD Student                            
Academy of Sciences; Czech Republic
                                                 
Homology modelling and molecular dynamics simulations of ion channels from TRP family
Vlastimil Zima
PhD Student                            
Charles University; Prague

Identification and Characterization of Natural and Synthetic Inhibitors of Receptor Operated Cation Channel, TRPC6
Sanjay Danthi                          
Staff Scientist II                       
GenZyme          
                       
GRC17536 - a novel, potent, selective and orally effective TRPA1 antagonist as a clinical lead for potential treatment of chronic inflammatory and neuropathic pain
Indranil Mukhopadhyay           
Principal Scientist                     
Glenmark Pharmaceuticals Ltd. 

High Expression of TRPV1 in Mammalian Cells
Rong Xia
Postdoc
Astrazeneca

June 29th, 2010

Enabling Ion Channel Screening through Improved Reagent Provision
Alexandra Alderton                 
Principal Scientist                     
Pfizer Global R&D

Validation of a high throughput twin pore potassium channel assay in the absence of selective tools
Juha Kammonen
Senior Scientist                     
Pfizer

Off target drug effects— mechanisms of and screening for amphiphile regulation of ion channel function through changes in lipid bilayer properties
Ruchi Kapoor
PhD Candidate
Weill Cornell Medical College

Dielectrophoresis-Based Single Cell Shuttling For Multi-Drug Resistance Study
Yuchun Chen
PhD Candidate
Simon Fraser University

Non-invasive MIFE ion flux measurements in ion channels research
Sergey Shabala
A/Professor
University of Tasmania

June 30th, 2010

Possible mediation of gentamycin uptake of MDCK cells via Connexin 43 hemichannels
Zhi-Gen Jiang
Associate Professor
Oregon Health & Science University

Cellular mechanism of the QT prolongation induced by sertraline
Hyang-Ae Lee                            
Research Scientist                    
Korea Institute of Toxicology

The SecY protein translocation channel is capable of ionic discrimination
Kush Dalal
PHd Student                            
University of British Columbia  
 
The regulation of N-type (Cav2.2) voltage-gated calcium channels by Cav subunit N- and C-terminal variable domains
Lele Song
Postdoctoral Fellow
University of Manchester

Interactions between agonists and CNG channels producing bimodal agonism
Wai Wong
BSc Candidate - Molecular Biology and Biochemistry
Simon Fraser University

For more information regarding the 2010 Ion Channel Retreat Speaking Program, please contact us at retreat@aurorabiomed.com

Return to Top of Page

Thank You to All Our Valued Sponsors and Partners

Corporate Sponsors
millipore Nanion Sophion Biosciences
cellectricon Molecular Devices Molecular Devices
Evotec Multi Channel Systems MCS Gmbh fluxion
Axiogenesis AG
Media Sponsors
addt laboratory focus laboratory focus
Media Partners
IonChannels.org ADMET.net HTScreening.net
BioScreening.com - Services for Drug Discovery AllConferences.Com:  Directory of Conferences, conventions, exhibits, seminars, workshops, events, trade shows and business meetings. Includes calendar, dates, location, web site, contact and registration information.